Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and magnesium sulfate in nervous system diseases
2015-000142-29Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ketamine and magnesium sulfate in neurological diseases, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Jun 2015; status: active.
02
Drugs
ketaminemagnesium sulfate
03
Conditions
neurological diseases
Beyond the preview
Go deeper on 2015-000142-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000142-29.